In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
Individual fit comes down to cost, coverage, and program mechanics rather than one being categorically different
If taste changes significantly impair nutrition or quality of life despite management strategies, your healthcare provider may consider dose reduction, temporary treatment interruption, or switching to an alternative medication
Understanding what to expect and how to manage symptoms helps patients stay compliant and reach their weight loss goals
Studies have shown that taking glutathione as a supplement can reduce the melanin formed by the skin and can produce melanin with lighter pigments instead of melanin with darker colors, allowing the skin to dilute up to three shades